Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epstein-barr virus-associated smooth muscle tumors after bone marrow transplantation.
Hayase E, Fujimoto K, Mitsuhashi T, Hatanaka Y, Yoshida M, Takemura R, Iwasaki J, Shiratori S, Sugita J, Kondo T, Tanaka J, Imamura M, Matsuno Y, Teshima T. Hayase E, et al. Among authors: fujimoto k. Transplantation. 2014 Jan 15;97(1):e1-3. doi: 10.1097/01.TP.0000437912.60638.23. Transplantation. 2014. PMID: 24374766 No abstract available.
c-myc rearrangement in B-cell lymphoblastic lymphoma with the involvement of multiple extranodal lesions.
Shiratori S, Kondo T, Fujisawa S, Kubota K, Kosugi M, Shono Y, Sugita J, Fujimoto K, Nishio M, Tanaka J, Koike T, Matsuno Y, Matsuno K, Asaka M, Imamura M. Shiratori S, et al. Among authors: fujimoto k. Leuk Lymphoma. 2011 Apr;52(4):716-8. doi: 10.3109/10428194.2010.551158. Epub 2011 Feb 14. Leuk Lymphoma. 2011. PMID: 21314486 No abstract available.
Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial.
Nishijima T, Gatanaga H, Shimbo T, Komatsu H, Endo T, Horiba M, Koga M, Naito T, Itoda I, Tei M, Fujii T, Takada K, Yamamoto M, Miyakawa T, Tanabe Y, Mitsuya H, Oka S; SPARE study team. Nishijima T, et al. PLoS One. 2013 Aug 8;8(8):e73639. doi: 10.1371/journal.pone.0073639. eCollection 2013. PLoS One. 2013. PMID: 23951362 Free PMC article. Clinical Trial.
Successful engraftment in HLA-mismatched bone marrow transplantation despite the persistence of high-level donor-specific anti-HLA-DR antibody.
Shiratori S, Ito M, Yoneoka M, Hayasaka K, Hayase E, Iwasaki J, Sugita J, Shigematsu A, Fujimoto K, Kondo T, Shimizu C, Teshima T. Shiratori S, et al. Among authors: fujimoto k. Transplantation. 2013 Sep 15;96(5):e34-44. doi: 10.1097/TP.0b013e31829f7595. Transplantation. 2013. PMID: 23995866 No abstract available.
Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation.
Shono Y, Shiratori S, Kosugi-Kanaya M, Ueha S, Sugita J, Shigematsu A, Kondo T, Hashimoto D, Fujimoto K, Endo T, Nishio M, Hashino S, Matsuno Y, Matsushima K, Tanaka J, Imamura M, Teshima T. Shono Y, et al. Among authors: fujimoto k. Biol Blood Marrow Transplant. 2014 Apr;20(4):495-500. doi: 10.1016/j.bbmt.2013.12.568. Epub 2013 Dec 27. Biol Blood Marrow Transplant. 2014. PMID: 24374213 Free article.
Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.
Shiratori S, Fujimoto K, Nishimura M, Hatanaka KC, Kosugi-Kanaya M, Okada K, Sugita J, Shigematsu A, Hashimoto D, Endo T, Kondo T, Abe R, Hashino S, Matsuno Y, Shimizu H, Teshima T. Shiratori S, et al. Among authors: fujimoto k. Hematol Oncol. 2016 Mar;34(1):9-16. doi: 10.1002/hon.2162. Epub 2014 Oct 14. Hematol Oncol. 2016. PMID: 25312300 Free article.
4,187 results